Cite
HARVARD Citation
Joyce, D. et al. (2022). Comparative cost‐effectiveness of neoadjuvant chemotherapy regimens for muscle‐invasive bladder cancer: Results according to VESPER data. Cancer. 128 (24), pp. 4194-4202. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Joyce, D. et al. (2022). Comparative cost‐effectiveness of neoadjuvant chemotherapy regimens for muscle‐invasive bladder cancer: Results according to VESPER data. Cancer. 128 (24), pp. 4194-4202. [Online].